🇪🇺 TDV in European Union

EMA authorised TDV on 5 December 2022

Marketing authorisation

EMA — authorised 5 December 2022

  • Application: EMEA/H/C/005155
  • Marketing authorisation holder: Takeda Pharmaceuticals International AG Ireland Branch
  • Local brand name: Qdenga
  • Indication: Qdenga is indicated for the prevention of dengue disease in individuals from 4 years of age. The use of Qdenga should be in accordance with official recommendations.
  • Status: approved

Read official source →

Other Diabetes approved in European Union

Frequently asked questions

Is TDV approved in European Union?

Yes. EMA authorised it on 5 December 2022.

Who is the marketing authorisation holder for TDV in European Union?

Takeda Pharmaceuticals International AG Ireland Branch holds the EU marketing authorisation.